Coenzyme Q10 (CoQ10) has become one of the most widely discussed supplements in reproductive medicine. As both an essential cofactor in mitochondrial energy production and a potent lipid-soluble antioxidant, CoQ10 sits at the intersection of two biological processes critical to fertility: cellular energy metabolism and oxidative stress defense. But does the evidence support its use for couples trying to conceive?
This article examines the current scientific literature on CoQ10 and fertility, covering its mechanisms of action, evidence in both female and male reproductive health, studied dosages, and safety considerations.
This article is for informational purposes only and does not constitute medical advice. Consult your physician before starting any supplement.
Table of Contents
- What Is CoQ10 and Why Does It Matter for Reproduction?
- The Mitochondrial Connection to Fertility
- What the Clinical Evidence Shows
- CoQ10 and Male Fertility
- Dosing: What the Studies Used
- Safety and Side Effects
- Frequently Asked Questions
- References
What Is CoQ10 and Why Does It Matter for Reproduction?
Coenzyme Q10, also known as ubiquinone, is a naturally occurring compound found in virtually every cell of the human body. It plays two essential roles: it functions as an electron carrier in the mitochondrial electron transport chain (ETC), where it is required for the production of adenosine triphosphate (ATP), and it acts as a powerful antioxidant, protecting cell membranes and lipoproteins from oxidative damage.[5]
These dual functions make CoQ10 particularly relevant to reproductive biology. Both oocytes (eggs) and spermatozoa are among the most metabolically demanding cells in the body. Oocytes require enormous amounts of ATP to support meiotic division, fertilization, and early embryonic development. Sperm cells, meanwhile, depend on mitochondrial energy production for motility and must withstand significant oxidative stress during their journey through the reproductive tract.
Endogenous CoQ10 production peaks around age 20 and gradually declines with age. This decline is thought to contribute to the age-related deterioration in oocyte quality and, more broadly, to diminished reproductive capacity in both sexes.[5]
The Mitochondrial Connection to Fertility
Oocyte Mitochondria and Egg Quality
The human oocyte contains more mitochondria than any other cell type — estimates range from 100,000 to over 600,000 per mature egg. This extraordinary mitochondrial density reflects the massive energy demands of oocyte maturation, chromosomal segregation during meiosis, fertilization, and early cleavage-stage embryonic development before mitochondrial biogenesis resumes.[5]
Nagaraju et al. (2026), in a comprehensive review published in Reproductive Sciences, detailed how mitochondrial dysfunction in oocytes represents a central mechanism in female infertility. The review highlighted that deficits in the electron transport chain — the very pathway where CoQ10 functions — lead to reduced ATP availability, increased production of reactive oxygen species (ROS), and impaired oocyte competence. The authors noted that mitochondrial DNA (mtDNA) copy number and mitochondrial membrane potential are emerging as key biomarkers of oocyte quality, and that mitochondrial dysfunction can result in meiotic spindle abnormalities, chromosomal aneuploidy, and failed implantation.[5]
This relationship between mitochondrial health and fertility outcomes becomes increasingly significant with advancing maternal age. Palomba et al. (2026) reviewed the aetiological mechanisms behind age-related female infertility in Reproductive Biomedicine Online, identifying mitochondrial dysfunction and oxidative stress accumulation as primary contributors to the decline in oocyte quality that accelerates after age 35. Their review noted that experimental interventions targeting mitochondrial function, including CoQ10 supplementation, represent an active area of investigation for improving outcomes in age-related fertility decline.[2]
Oxidative Stress: The Common Enemy
Oxidative stress — defined as an imbalance between ROS production and antioxidant defense — is implicated in virtually every dimension of reproductive impairment. In the ovarian environment, excess ROS damages oocyte DNA, disrupts spindle formation, and accelerates follicular atresia. In the male reproductive system, spermatozoa are particularly vulnerable to lipid peroxidation of their polyunsaturated fatty acid-rich membranes, leading to DNA fragmentation and impaired motility.[7][8]
Xie et al. (2025), in a review published in Frontiers in Endocrinology, examined the role of antioxidant strategies in combating ovarian aging. The authors discussed CoQ10 as one of several antioxidant compounds that may help preserve female reproductive capacity by mitigating oxidative damage to ovarian tissue and oocytes. Their analysis highlighted the importance of maintaining redox homeostasis in the ovarian microenvironment for both natural fertility and assisted reproduction outcomes.[8]
What the Clinical Evidence Shows
CoQ10 and Female Fertility
The rationale for CoQ10 supplementation in female fertility rests on its dual role in supporting mitochondrial ATP production and reducing oxidative damage in oocytes. The theoretical framework is well-established: CoQ10 levels decline with age, oocytes are extraordinarily dependent on mitochondrial function, and mitochondrial dysfunction is strongly associated with poor oocyte quality and fertility outcomes.[5]
Toner et al. The authors discussed how adjunct supplementation strategies aimed at enhancing mitochondrial bioenergetics may complement standard IVF protocols, particularly for women with diminished ovarian reserve (DOR) or advanced maternal age.
Several earlier clinical trials have investigated CoQ10 specifically in the context of IVF and ovarian stimulation. These studies have generally explored whether pre-treatment with CoQ10 can improve ovarian response, increase oocyte yield, or reduce aneuploidy rates in women undergoing assisted reproduction. While some results have been promising — particularly in subgroups of older women or those with DOR — the evidence base remains limited by small sample sizes and heterogeneous study designs.
CoQ10 Supplementation in Fertility Treatment Populations
Sealy et al. (2026), in a study published in Fertility and Sterility, examined supplement use among couples seeking fertility treatment and evaluated associations with clinical outcomes including live birth and pregnancy loss. This study provides real-world data on supplement use in fertility populations, though specific outcome data for individual supplements like CoQ10 should be interpreted within the study's broader methodology and limitations.
It is important to note that while the biological rationale for CoQ10 in female fertility is compelling, the current clinical evidence consists largely of small-to-moderate-sized trials and observational data. Large, multicenter randomized controlled trials powered for live birth as a primary outcome remain needed to establish definitive efficacy.
Ovarian Aging and Antioxidant Interventions
The broader literature on antioxidant interventions for ovarian aging provides additional context for understanding CoQ10's potential role. Xie et al. (2025) noted that the ovarian environment is particularly susceptible to cumulative oxidative damage over time, and that antioxidant supplementation represents a plausible strategy for slowing age-related decline in oocyte quality. CoQ10 was discussed among several antioxidant compounds that may help maintain redox balance in the ovary, though the authors emphasized that translating preclinical promise into clinical practice requires rigorous human trials.[8]
CoQ10 and Male Fertility
Oxidative Stress and Sperm Function
The case for CoQ10 in male fertility centers on the well-documented role of oxidative stress in sperm dysfunction. Ajayi et al. (2026), in a review published in Molecular Biology Reports, comprehensively examined oxidative stress as a cause of male infertility, including diagnostic biomarkers and the efficacy of antioxidant therapy. The authors detailed how excessive ROS generation overwhelms the limited antioxidant defenses of spermatozoa, leading to lipid peroxidation of sperm membranes, mitochondrial damage, DNA fragmentation, and impaired motility and acrosomal function. Their review identified CoQ10 among the antioxidant compounds that have been investigated for their capacity to counteract oxidative damage to sperm.[7]
Ramgir-Naidu et al. (2026), in a molecular-focused scoping review published in the Journal of Health, Population, and Nutrition, examined the broader landscape of nutritional modulation of male fertility. The review synthesized evidence on how various nutrients and supplements, including CoQ10, influence male reproductive outcomes at the molecular level. CoQ10 was discussed in the context of its role in mitochondrial bioenergetics and antioxidant defense within spermatozoa, supporting the biological plausibility of supplementation for improving sperm parameters.[1]
Seminal CoQ10 Levels and Sperm Quality
CoQ10 is found in high concentrations in seminal fluid, where it serves both as an intracellular mitochondrial cofactor within sperm and as an extracellular antioxidant in seminal plasma. Multiple studies have reported positive correlations between seminal CoQ10 concentrations and sperm count, motility, and morphology, though the direction of causality — whether low CoQ10 causes poor sperm parameters or is merely a marker of underlying dysfunction — is not fully resolved.
Preclinical Evidence
Preclinical data provides additional mechanistic support. Rasaei et al. (2026), publishing in Veterinary Research Communications, demonstrated the protective effects of CoQ10-supplemented cryopreservation medium on oxidative stress in frozen canine sperm. While this is an animal study with a specific application to sperm cryopreservation rather than in vivo supplementation, it provides direct evidence of CoQ10's antioxidant capacity in protecting sperm cells from ROS-induced damage. The study showed that CoQ10 supplementation reduced markers of oxidative stress and improved post-thaw sperm viability.[4]
It should be noted that while preclinical and in vitro evidence for CoQ10's protective effects on sperm is relatively consistent, human clinical trials have produced more variable results. Some RCTs have reported improvements in sperm concentration, motility, and morphology with CoQ10 supplementation , while others have found more modest or non-significant effects. Differences in study populations, CoQ10 formulations, dosing, and duration likely account for some of this variability.
Dosing: What the Studies Used
Dosing in CoQ10 fertility research has varied considerably across studies, though certain ranges emerge from the available literature:
Female Fertility Studies
Clinical trials investigating CoQ10 for female fertility have typically used doses ranging from 200 mg to 600 mg per day, with supplementation periods of 60 days to 3 months prior to IVF cycles. Some protocols have used higher doses of up to 600 mg/day in women with diminished ovarian reserve. No standardized dosing protocol exists, and the optimal dose-response relationship has not been established in large trials.
Male Fertility Studies
Studies in male fertility have generally used doses of 200 mg to 300 mg per day for durations of 3 to 6 months — aligning with the approximately 74-day spermatogenesis cycle. Both the ubiquinone and ubiquinol forms of CoQ10 have been studied, with ubiquinol (the reduced, active form) demonstrating higher bioavailability.
Formulation Considerations
CoQ10 is a lipophilic molecule with inherently poor oral bioavailability. Absorption is enhanced when taken with a fat-containing meal. Ubiquinol formulations generally achieve higher plasma concentrations than ubiquinone at equivalent doses, though both forms have been used in clinical studies. Softgel formulations with lipid-based carriers tend to outperform dry powder capsules or tablets in terms of absorption.
It is critical to note that supplementation must begin well in advance of conception attempts or fertility treatments. Oocyte maturation requires approximately 3 months from primordial follicle recruitment to ovulation, and spermatogenesis takes roughly 74 days. Therefore, most researchers recommend initiating CoQ10 supplementation at least 2 to 3 months before planned conception or IVF treatment.
Safety and Side Effects
CoQ10 has a well-established safety profile. It is generally well tolerated at doses up to 1,200 mg/day in clinical studies, though doses used in fertility research are typically lower (200–600 mg/day).
Common Side Effects
Reported side effects are generally mild and infrequent, including gastrointestinal symptoms such as nausea, diarrhea, and appetite suppression. These effects are usually dose-dependent and resolve with dose reduction. Dividing the daily dose across multiple administrations and taking CoQ10 with meals can minimize gastrointestinal discomfort.
Drug Interactions
The most clinically significant interaction is with warfarin and other anticoagulants. CoQ10 is structurally similar to vitamin K and may reduce the anticoagulant effect of warfarin, potentially requiring dose adjustments. Patients on blood-thinning medications should consult their prescribing physician before initiating CoQ10.
Statin medications (HMG-CoA reductase inhibitors) are known to reduce endogenous CoQ10 synthesis by inhibiting the mevalonate pathway. While the clinical significance of statin-induced CoQ10 depletion is debated, individuals taking statins may have lower baseline CoQ10 levels, which could be relevant in a fertility context.
Pregnancy and Lactation
Data on CoQ10 supplementation during pregnancy is limited. While some studies have used CoQ10 in preconception protocols, routine supplementation during pregnancy is not well-studied. Pregnant or breastfeeding women should discuss CoQ10 use with their healthcare provider.
Frequently Asked Questions
Does CoQ10 improve egg quality?
The biological rationale is strong: CoQ10 supports mitochondrial ATP production in oocytes and provides antioxidant protection against age-related oxidative damage.[5] Mitochondrial dysfunction is recognized as a key contributor to declining oocyte quality with age.[2] However, while preliminary clinical studies have been encouraging, large definitive trials proving CoQ10 improves egg quality and live birth rates are still lacking. Evidence suggests potential benefit, particularly for women of advanced maternal age or those with diminished ovarian reserve, but more research is needed.
Can CoQ10 help with male infertility?
Oxidative stress is a well-established contributor to male infertility, and CoQ10 is one of the most studied antioxidants in this context.[7] Reviews of nutritional interventions for male fertility have identified CoQ10 as a compound with a plausible molecular mechanism for improving sperm parameters.[1] Preclinical studies have demonstrated its protective effects against oxidative damage to sperm.[4] Human clinical data is mixed but generally supportive, with some trials showing improvements in sperm motility and concentration. CoQ10 should be considered as part of a broader antioxidant and lifestyle strategy rather than a standalone treatment.
Should both partners take CoQ10 when trying to conceive?
Given that CoQ10 addresses mechanisms relevant to both egg and sperm quality — specifically mitochondrial function and oxidative stress defense — there is a reasonable rationale for both partners to consider supplementation.[5][7] However, individual circumstances vary, and supplementation decisions should be made in consultation with a fertility specialist or physician, particularly for individuals on medications or with pre-existing health conditions.
How long should I take CoQ10 before IVF or trying to conceive?
Based on the biology of gamete development — approximately 3 months for oocyte maturation from follicle recruitment to ovulation, and approximately 74 days for a complete spermatogenesis cycle — most clinical protocols have initiated CoQ10 supplementation at least 2 to 3 months before fertility treatment or planned conception attempts. Starting supplementation earlier allows CoQ10 to influence the developing gametes during their most metabolically active maturation phases.
Is ubiquinol better than ubiquinone for fertility?
Ubiquinol (the reduced form) has greater oral bioavailability than ubiquinone (the oxidized form), meaning higher plasma concentrations can be achieved at equivalent doses. However, both forms are interconverted in the body, and both have been used in clinical studies. No head-to-head clinical trial has definitively demonstrated superiority of one form over the other specifically for fertility outcomes. Ubiquinol may be preferred when lower doses are desired or when absorption is a concern, but either form is considered acceptable.
References
- Ramgir-Naidu S, Abubakar YA, Soni M. "Nutritional modulation of male fertility: a molecular-focused scoping review." Journal of Health, Population, and Nutrition, 2026. DOI: 10.1186/s41043-026-01374-y
- Palomba S, Seminara G, Sarica M et al. "Age-related female infertility: aetiological mechanisms and evidence-based and experimental interventions." Reproductive Biomedicine Online, 2026. DOI: 10.1016/j.rbmo.2026.105734
- Rasaei A, Moghaddam AA, Feyli PR. "Protective effects of coenzyme Q10-supplemented cryopreservation medium on oxidative stress in frozen canine sperm." Veterinary Research Communications, 2026. DOI: 10.1007/s11259-026-11235-y
- Nagaraju S, Ahmed SS, Raghunathnaidu BD et al. "Mitochondrial Function and Dysfunction in Female Fertility: Biological Mechanisms, Genetic Determinants, and Therapeutic Opportunities - A Review." Reproductive Sciences (Thousand Oaks, Calif.), 2026. DOI: 10.1007/s43032-026-02113-8
- Ajayi AF, Oyowvi MO, Onaolapo MC. "The critical role of oxidative stress in male infertility: causes, diagnostic biomarkers, and the efficacy of antioxidant therapy." Molecular Biology Reports, 2026. DOI: 10.1007/s11033-026-11714-0
- Xie B, Zhang K, Lin J et al. "Female reproductive capacity preservation: antioxidant strategies in combating ovarian aging and cryopreservation challenges." Frontiers in Endocrinology, 2025. DOI: 10.3389/fendo.2025.1711016
